Production (Stage)
Caribou Biosciences, Inc.
CRBU
$1.19
$0.076.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.29% | -46.08% | -56.65% | -11.01% | -6.35% |
| Total Depreciation and Amortization | 20.19% | 11.40% | 5.83% | 79.69% | 91.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.50% | -3.82% | 140.76% | 49.46% | 38.92% |
| Change in Net Operating Assets | 0.76% | 30.12% | 133.78% | -269.06% | -298.15% |
| Cash from Operations | -34.29% | -48.14% | -28.01% | -32.79% | -5.47% |
| Capital Expenditure | 59.44% | 57.98% | 40.15% | -39.29% | -42.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 314.01% | 261.70% | 287.52% | -239.58% | -849.69% |
| Cash from Investing | 271.44% | 227.02% | 210.31% | -326.82% | -14,918.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.15% | -89.16% | -91.67% | 638.95% | 5,831.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.15% | -89.16% | -91.70% | 638.73% | 5,829.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -497.58% | -385.91% | -428.08% | 38.35% | 96.48% |